Korean Market
EXCH
Samik Pharm
★

Samik Pharm Calls Temporary Shareholders' Meeting to Add Medical Device Business and Revise Stock Option Terms

 
EXCH
Samik Pharm
★

Samik Pharm sets record date for extraordinary general meeting to confirm shareholders; no impact on shareholder value

 
OWNR
Samik Pharm
★

No Change in Specific Securities Holdings by Officers and Major Shareholders

 
PERI
Samik Pharm
★★

Samik Pharmaceutical Q1 2026: Consolidated Revenue KRW 15.5B, Net Profit KRW 1.2B; New Drug Approval and Pipeline Strength

 
EXCH
Samik Pharm
★★★★

Samik Pharmaceuticals announces 2026 value-up plan and continued high dividend